Secondary |
Drug Use For Unknown Indication |
17.0% |
Cardiac Failure |
9.1% |
Hypertension |
9.1% |
Atrial Fibrillation |
8.0% |
Parkinson's Disease |
6.8% |
Cerebral Infarction |
4.5% |
Diabetes Mellitus |
4.5% |
Insomnia |
4.5% |
Pollakiuria |
4.5% |
Supraventricular Tachycardia |
4.5% |
Angina Pectoris |
3.4% |
Constipation |
3.4% |
Dementia Alzheimer's Type |
3.4% |
Rheumatoid Arthritis |
3.4% |
Back Pain |
2.3% |
Catheter Related Infection |
2.3% |
Gastric Ulcer Haemorrhage |
2.3% |
Gastritis |
2.3% |
Headache |
2.3% |
Iron Deficiency Anaemia |
2.3% |
|
Agranulocytosis |
13.3% |
Pollakiuria |
13.3% |
Toxic Epidermal Necrolysis |
13.3% |
Visual Disturbance |
13.3% |
Deafness Neurosensory |
6.7% |
Drug Interaction |
6.7% |
Loss Of Consciousness |
6.7% |
Miosis |
6.7% |
Vasculitis |
6.7% |
Vision Blurred |
6.7% |
Vomiting |
6.7% |
|
Concomitant |
Atrial Fibrillation |
14.3% |
Cardiac Failure |
12.8% |
Hypertension |
11.0% |
Product Used For Unknown Indication |
10.5% |
Drug Use For Unknown Indication |
7.2% |
Cardiac Failure Chronic |
6.8% |
Pulmonary Hypertension |
6.3% |
Angina Pectoris |
4.0% |
Gastrointestinal Disorder |
3.7% |
Constipation |
3.2% |
Diabetes Mellitus |
2.4% |
Cardiac Failure Congestive |
2.3% |
Gastritis |
2.2% |
Crohn's Disease |
2.0% |
Insomnia |
2.0% |
Prophylaxis |
2.0% |
Hepatitis C |
1.9% |
Reflux Oesophagitis |
1.9% |
B-cell Lymphoma |
1.7% |
Hyperlipidaemia |
1.7% |
|
Cardiac Failure |
7.7% |
Renal Failure Acute |
7.7% |
Gastric Ulcer Haemorrhage |
6.4% |
Interstitial Lung Disease |
6.4% |
Right Ventricular Failure |
6.4% |
Vomiting |
6.4% |
Hepatic Function Abnormal |
5.1% |
Hypernatraemia |
5.1% |
Pneumonia |
5.1% |
Sudden Death |
5.1% |
Cholecystitis |
3.8% |
Gastrointestinal Haemorrhage |
3.8% |
Hepatic Rupture |
3.8% |
Hypoglycaemia |
3.8% |
Platelet Count Decreased |
3.8% |
Rash |
3.8% |
Respiratory Failure |
3.8% |
Shock |
3.8% |
Thirst |
3.8% |
Thrombocytopenia |
3.8% |
|
Interacting |
Hypertension |
28.6% |
Thrombosis Prophylaxis |
28.6% |
Abdominal Pain Upper |
14.3% |
Atrial Fibrillation |
14.3% |
Hyperglycaemia |
14.3% |
|
Ventricular Extrasystoles |
100.0% |
|